NHS rejects cancer drugs due to costs
Thursday, August 7, 2008 - 22:07
in Health & Medicine
LONDON, Aug. 7 (UPI) -- Britain's National Health Service said it rejected four new drugs designed to treat advanced kidney cancer because the cost is too high.
Read the whole article on UPI
More from UPI
Related
- Affordable anti-rejection drug as effective as higher cost optionWed, 14 Oct 2009, 12:43:53 EDT
- One in ten advanced colon cancer patients worry about prescription drug costsFri, 29 May 2009, 11:11:10 EDT
- Gene mutation increases drug toxicity, rejection risk in pediatric kidney transplantsWed, 18 Feb 2009, 9:56:22 EST
- Cancer drug effectively treats transplant rejectionsSat, 27 Dec 2008, 4:15:47 EST
- Drug may prolong organ life in noncompliant kidney transplant patientsSat, 31 May 2008, 3:42:36 EDT